Crossmark

Real-life evaluation of the 2017 McDonald criteria for relapsing–remitting multiple sclerosis after a clinically isolated syndrome confirms a gain in time-to-diagnosis

Crossref DOI link: https://doi.org/10.1007/s00415-023-11905-w

Published Online: 2023-08-31

Published Print: 2024-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ferrand, Mickaël

Epstein, Jonathan

Soudant, Marc

Guillemin, Francis

Pittion-Vouyovitch, Sophie

Debouverie, Marc

Mathey, Guillaume https://orcid.org/0000-0002-5747-9169
License Information

Text and Data Mining valid from 2023-08-31

Version of Record valid from 2023-08-31
More Information

Article History

Received: 25 May 2023

Revised: 25 July 2023

Accepted: 25 July 2023

First Online: 31 August 2023

Declarations

:

: MF, JE, MS, SPV, MD and GM declare no conflict of interest in line with this work. FG reports grants from Roche, Merck and Biogen to his institution.

Document is current

Any future updates will be listed below